YS Biopharma (YS) Short Interest Ratio & Short Volume → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free YS Stock Alerts $0.97 +0.02 (+2.11%) (As of 05/10/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media YS Biopharma Short Interest DataCurrent Short Volume56,700 sharesPrevious Short Volume95,900 sharesChange Vs. Previous Month-40.88%Dollar Volume Sold Short$41,164.20Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares93,060,000 sharesFloat Size17,940,000 sharesShort Percent of Float0.32%Today's Trading Volume170,929 sharesAverage Trading Volume124,659 sharesToday's Volume Vs. Average137% Short Selling YS Biopharma ? Sign up to receive the latest short interest report for YS Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatYS Short Interest Over TimeYS Days to Cover Over TimeYS Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… YS Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202456,700 shares $41,164.20 -40.9%0.3%0.3 $0.73 4/15/202495,900 shares $85,351.00 -1.0%0.5%0.4 $0.89 3/31/202496,900 shares $69,758.21 -17.0%0.5%0.5 $0.72 3/15/2024116,800 shares $84,446.40 -51.6%0.7%0.6 $0.72 2/29/2024241,400 shares $91,732.00 +25.5%1.4%1.3 $0.38 2/15/2024192,300 shares $80,439.09 +124.7%1.1%1.3 $0.42 Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. 1/31/202485,600 shares $36,294.40 +1.7%0.4%0.6 $0.42 1/15/202484,200 shares $44,617.58 -28.5%0.4%0.8 $0.53 12/31/2023117,800 shares $60,195.80 -33.1%0.6%1.3 $0.51 12/15/2023176,200 shares $85,738.92 +7.8%0.9%1.9 $0.49 11/30/2023163,500 shares $91,560.00 -18.2%0.8%1.4 $0.56 11/15/2023199,900 shares $131,734.10 +52.0%1.0%0.2 $0.66 10/31/2023131,500 shares $57,860.00 -12.0%0.7%0.1 $0.44 10/15/2023149,400 shares $103,833.00 +124.7%0.8%0.2 $0.70 9/30/202366,500 shares $53,200.00 -32.4%0.3%0.1 $0.80 9/15/202398,300 shares $88,470.00 -86.1%0.5%0.1 $0.90 8/31/2023706,300 shares $840,497.00 +198.5%3.5%0.5 $1.19 8/15/2023236,600 shares $286,286.00 -23.7%1.2%0.4 $1.21 7/31/2023309,900 shares $440,058.00 +36.2%1.6%0.5 $1.42 7/15/2023227,600 shares $316,364.00 -18.1%1.1%0.3 $1.39 6/30/2023277,800 shares $383,364.00 -83.1%1.4%0.3 $1.38 6/15/20231,640,000 shares $2.26 million +86.1%8.3%1.3 $1.38 5/31/2023881,100 shares $1.33 million -3.3%4.4%1.1 $1.51 5/15/2023911,100 shares $1.13 million No Change4.6%1.2 $1.24 YS Short Interest - Frequently Asked Questions What is YS Biopharma's current short interest? Short interest is the volume of YS Biopharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 56,700 shares of YS short. 0.32% of YS Biopharma's shares are currently sold short. Learn More on YS Biopharma's current short interest. What is a good short interest percentage for YS Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of YS Biopharma's floating shares are currently sold short. Is YS Biopharma's short interest increasing or decreasing? YS Biopharma saw a decrease in short interest in April. As of April 30th, there was short interest totaling 56,700 shares, a decrease of 40.9% from the previous total of 95,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is YS Biopharma's float size? YS Biopharma currently has issued a total of 93,060,000 shares. Some of YS Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. YS Biopharma currently has a public float of 17,940,000 shares. How does YS Biopharma's short interest compare to its competitors? 0.32% of YS Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to YS Biopharma: Rallybio Co. (9.67%), Landos Biopharma, Inc. (0.05%), MediciNova, Inc. (0.46%), SCYNEXIS, Inc. (2.58%), Carisma Therapeutics, Inc. (9.41%), vTv Therapeutics Inc. (3.18%), Journey Medical Co. (4.07%), Mural Oncology plc (11.13%), Assembly Biosciences, Inc. (0.68%), Aileron Therapeutics, Inc. (0.98%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short YS Biopharma stock? Short selling YS is an investing strategy that aims to generate trading profit from YS Biopharma as its price is falling. YS shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against YS Biopharma? A short squeeze for YS Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of YS, which in turn drives the price of the stock up even further. How often is YS Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Rallybio Short Squeeze Landos Biopharma Short Squeeze MediciNova Short Squeeze SCYNEXIS Short Squeeze Carisma Therapeutics Short Squeeze vTv Therapeutics Short Squeeze Journey Medical Short Squeeze Mural Oncology Short Squeeze Assembly Biosciences Short Squeeze Aileron Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:YS) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlaceGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing